The Community Guide

- gsearch

Search Results

All Collections

Morbidity and Mortality Weekly Report (MMWR)

The Morbidity and Mortality Weekly Report (MMWR) series are CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements. These journals are freely available to the public as Diamond Open Access. For more on MMWR, visit https://www.cdc.gov/mmwr/index.html.

Narrow Results:

2025 3
2024 176
2023 1

Reproductive Health 2

1 - 20 of 180 Results

Refine Results

Refine Results:

Supplementary Table. Frequency and Average Annual Incidence of Tularemia Cases by Demographic Characteristics Overall and Stratified by Case Status — United States, 2011–2022

CITE Title : Supplementary Table. Frequency and Average Annual Incidence of Tularemia Cases by Demographic Characteristics Overall and Stratified by Case Status — United States, 2011–2022 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 01/02/2025 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2025; v. 73, no. 51 & 52 URL : https://stacks.cdc.gov/view/cdc/174815 Centers for Disease Control and Prevention (U.S.). (2025). Supplementary Table. Frequency and Average Annual Incidence of Tularemia Cases by Demographic Characteristics Overall and Stratified by Case Status — United States, 2011–2022. 73 Centers for Disease Control and Prevention (U.S.). "Supplementary Table. Frequency and Average Annual Incidence of Tularemia Cases by Demographic Characteristics Overall and Stratified by Case Status — United States, 2011–2022" 73 (2025) Centers for Disease Control and Prevention (U.S.). "Supplementary Table. Frequency and Average Annual Incidence of Tularemia Cases by Demographic Characteristics Overall and Stratified by Case Status — United States, 2011–2022" vol. 73, 2025 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

01/02/2025 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Table. Morbidity and Mortality Weekly Report, Vol. 73, No. 51-52, January 2, 2025
Supplementary Figure. Average Annual Tularemia Incidence, by Age Group and Sex — United States, 2011–2022

CITE Title : Supplementary Figure. Average Annual Tularemia Incidence, by Age Group and Sex — United States, 2011–2022 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 01/02/2025 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2025; v. 73, no. 51 & 52 URL : https://stacks.cdc.gov/view/cdc/174814 Centers for Disease Control and Prevention (U.S.). (2025). Supplementary Figure. Average Annual Tularemia Incidence, by Age Group and Sex — United States, 2011–2022. 73 Centers for Disease Control and Prevention (U.S.). "Supplementary Figure. Average Annual Tularemia Incidence, by Age Group and Sex — United States, 2011–2022" 73 (2025) Centers for Disease Control and Prevention (U.S.). "Supplementary Figure. Average Annual Tularemia Incidence, by Age Group and Sex — United States, 2011–2022" vol. 73, 2025 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

01/02/2025 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Table. Morbidity and Mortality Weekly Report, Vol. 73, No. 51-52, January 2, 2025
MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 51 & 52, January 2, 2025

CITE Title : MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 51 & 52, January 2, 2025 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 01/02/2025 Pages in Document : 12 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2025; v. 73, no. 51 & 52 URL : https://stacks.cdc.gov/view/cdc/175292 Journal Title : MMWR. Morbidity and Mortality Weekly Report Centers for Disease Control and Prevention (U.S.) (2025). MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 51 & 52, January 2, 2025. 73 Centers for Disease Control and Prevention (U.S.) "MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 51 & 52, January 2, 2025" 73 (2025) Centers for Disease Control and Prevention (U.S.) "MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 51 & 52, January 2, 2025" vol. 73, 2025 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

01/02/2025 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

MMWR Weekly: Volume (73), No. 51 & 52: Articles in this issue:Tularemia — United States, 2011–2022Outbreak of Blastomycosis Among Paper Mill Worke...
Vital Signs: Drowning Death Rates, Self-Reported Swimming Skill, Swimming Lesson Participation, and Recreational Water Exposure — United States, 2019–2023

CITE Title : Vital Signs: Drowning Death Rates, Self-Reported Swimming Skill, Swimming Lesson Participation, and Recreational Water Exposure — United States, 2019–2023 Personal Author(s) : Clemens, Tessa;Moreland, Briana;Mack, Karin A.;Thomas, Karen;Bergen, Gwen;Lee, Robin; Corporate Authors(s) : National Center for Injury Prevention and Control (U.S.). Division of Injury Prevention. Published Date : May 14, 2024 Pages in Document : 12 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73 Early Release URL : https://stacks.cdc.gov/view/cdc/156291 Clemens, Tessa et al. (2024). Vital Signs: Drowning Death Rates, Self-Reported Swimming Skill, Swimming Lesson Participation, and Recreational Water Exposure — United States, 2019–2023. 73 Clemens, Tessa et al. "Vital Signs: Drowning Death Rates, Self-Reported Swimming Skill, Swimming Lesson Participation, and Recreational Water Exposure — United States, 2019–2023" 73 (2024) Clemens, Tessa et al. "Vital Signs: Drowning Death Rates, Self-Reported Swimming Skill, Swimming Lesson Participation, and Recreational Water Exposure — United States, 2019–2023" vol. 73, 2024 Export RIS Citation Information.

:

Clemens, Tessa ;

Moreland, Briana

May 14, 2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? Approximately 4,000 unintentional drowning deaths occur annually in the United States, and demographic dispari...
Notice to Readers: Change in Publication Date of MMWR Series

CITE Title : Notice to Readers: Change in Publication Date of MMWR Series Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 01/11/2024 Pages in Document : 1 Page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 1 DOI : http://dx.plos.org/10.15585/mmwr.mm7301a5 Centers for Disease Control and Prevention (U.S.) (2024). Notice to Readers: Change in Publication Date of MMWR Series. 73(1). http://dx.plos.org/10.15585/mmwr.mm7301a5 Centers for Disease Control and Prevention (U.S.) "Notice to Readers: Change in Publication Date of MMWR Series" 73, no. 1 (2024), http://dx.plos.org/10.15585/mmwr.mm7301a5 Centers for Disease Control and Prevention (U.S.) "Notice to Readers: Change in Publication Date of MMWR Series" vol. 73, no. 1, 2024, http://dx.plos.org/10.15585/mmwr.mm7301a5 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

01/11/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

No Description
National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020

CITE Title : National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : January 25, 2024 Pages in Document : 73 pdf pages Series : Supplements: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR. Supplements 2024; v. 73, no. 1 URL : https://stacks.cdc.gov/view/cdc/145980 Centers for Disease Control and Prevention (U.S.) (2024). National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020. 73(1). Centers for Disease Control and Prevention (U.S.) "National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020" 73, no. 1 (2024) Centers for Disease Control and Prevention (U.S.) "National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020" vol. 73, no. 1, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

January 25, 2024 | Supplements: Morbidity and Mortality Weekly Report (MMWR)

:

Overview and Methodology of the National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020 -- Char...
Supplementary Table 1. Vaccine Effectiveness of Bivalent Compared with Effectiveness of Original Monovalent Vaccination Against COVID-19-related Thromboembolic Events Among Medicare Beneficiaries Aged ≥65 Years with Immunocompromise and Beneficiaries Aged ≥18 Years with End Stage Renal Disease Receiving Dialysis with Immunocompromise, by Age Group and Time Since Vaccination — United States, September 2022–March 2023

CITE Title : Supplementary Table 1. Vaccine Effectiveness of Bivalent Compared with Effectiveness of Original Monovalent Vaccination Against COVID-19-related Thromboembolic Events Among Medicare Beneficiaries Aged ≥65 Years with Immunocompromise and Beneficiaries Aged ≥18 Years with End Stage Renal Disease Receiving Dialysis with Immunocompromise, by Age Group and Time Since Vaccination — United States, September 2022–March 2023 Published Date : January 11, 2024 Pages in Document : 2 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 1 URL : https://stacks.cdc.gov/view/cdc/140316 "Supplementary Table 1. Vaccine" (2024). 73(1). "Supplementary Table 1. Vaccine Effectiveness of Bivalent Compared with Effectiveness of Original Monovalent Vaccination Against COVID-19-related Thromboembolic Events Among Medicare Beneficiaries Aged ≥65 Years with Immunocompromise and Beneficiaries Aged ≥18 Years with End Stage Renal Disease Receiving Dialysis with Immunocompromise, by Age Group and Time Since Vaccination — United States, September 2022–March 2023" 73, no. 1 (2024) "Supplementary Table 1. Vaccine Effectiveness of Bivalent Compared with Effectiveness of Original Monovalent Vaccination Against COVID-19-related Thromboembolic Events Among Medicare Beneficiaries Aged ≥65 Years with Immunocompromise and Beneficiaries Aged ≥18 Years with End Stage Renal Disease Receiving Dialysis with Immunocompromise, by Age Group and Time Since Vaccination — United States, September 2022–March 2023" vol. 73, no. 1, 2024 Export RIS Citation Information.

January 11, 2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

No Description
Supplementary Table 2. Vaccine Effectiveness of Bivalent Compared with Effectiveness of Original Monovalent Vaccination Against All-cause Thromboembolic Events Among Immunocompetent Medicare Beneficiaries Aged ≥65 Years and Beneficiaries Aged ≥18 Years with End Stage Renal Disease Receiving Dialysis Without Additional Immunocompromising Conditions, by Age Group and Time Since Vaccination — United States, September 2022–March 2023

CITE Title : Supplementary Table 2. Vaccine Effectiveness of Bivalent Compared with Effectiveness of Original Monovalent Vaccination Against All-cause Thromboembolic Events Among Immunocompetent Medicare Beneficiaries Aged ≥65 Years and Beneficiaries Aged ≥18 Years with End Stage Renal Disease Receiving Dialysis Without Additional Immunocompromising Conditions, by Age Group and Time Since Vaccination — United States, September 2022–March 2023 Published Date : January 11, 2024 Pages in Document : 2 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 1 URL : https://stacks.cdc.gov/view/cdc/140315 "Supplementary Table 2. Vaccine" (2024). 73(1). "Supplementary Table 2. Vaccine Effectiveness of Bivalent Compared with Effectiveness of Original Monovalent Vaccination Against All-cause Thromboembolic Events Among Immunocompetent Medicare Beneficiaries Aged ≥65 Years and Beneficiaries Aged ≥18 Years with End Stage Renal Disease Receiving Dialysis Without Additional Immunocompromising Conditions, by Age Group and Time Since Vaccination — United States, September 2022–March 2023" 73, no. 1 (2024) "Supplementary Table 2. Vaccine Effectiveness of Bivalent Compared with Effectiveness of Original Monovalent Vaccination Against All-cause Thromboembolic Events Among Immunocompetent Medicare Beneficiaries Aged ≥65 Years and Beneficiaries Aged ≥18 Years with End Stage Renal Disease Receiving Dialysis Without Additional Immunocompromising Conditions, by Age Group and Time Since Vaccination — United States, September 2022–March 2023" vol. 73, no. 1, 2024 Export RIS Citation Information.

January 11, 2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

No Description
Overview and Methodology of the National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020

CITE Title : Overview and Methodology of the National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 01/26/2024 Pages in Document : gau Series : Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, 2024; v. 73, no. 1 URL : https://stacks.cdc.gov/view/cdc/137444 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries Centers for Disease Control and Prevention (U.S.) (2024). Overview and Methodology of the National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020. 73(1). Centers for Disease Control and Prevention (U.S.) "Overview and Methodology of the National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020" 73, no. 1 (2024) Centers for Disease Control and Prevention (U.S.) "Overview and Methodology of the National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020" vol. 73, no. 1, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

01/26/2024 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)

No Description
Laboratory Recommendations for Syphilis Testing in the United States – Supplementary Material

CITE Title : Laboratory Recommendations for Syphilis Testing in the United States – Supplementary Material Corporate Authors(s) : National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.;National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Preparedness and Emerging Infections.;University of California San Diego School of Medicine.;University of Florida College of Pharmacy.;Beth Israel Deaconess Medical Center.;University of Utah School of Medicine.;National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention). Division of Birth Defects and Infant Disorders.;National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention). Division of Human Development and Disability.; Published Date : January 2024 Pages in Document : 85 pdf page Series : Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, 2024; v. 73, no. 1 URL : https://stacks.cdc.gov/view/cdc/138288 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. (2024). Laboratory Recommendations for Syphilis Testing in the United States – Supplementary Material. 73(1). National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. "Laboratory Recommendations for Syphilis Testing in the United States – Supplementary Material" 73, no. 1 (2024) National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. "Laboratory Recommendations for Syphilis Testing in the United States – Supplementary Material" vol. 73, no. 1, 2024 Export RIS Citation Information.

:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. ...

January 2024 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Table 1. Performance characteristics of nontreponemal (lipoidal antigen) serologic tests used for the diagnosis of syphilisSupplementary...
CDC Laboratory Recommendations for Syphilis Testing, United States, 2024

CITE Title : CDC Laboratory Recommendations for Syphilis Testing, United States, 2024 Personal Author(s) : Papp, John R.;Park, Ina U.;Fakile, Yetunde;Pereira, Lara;Pillay, Allan;Bolan, Gail A.; Corporate Authors(s) : National Center for HIV, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention.;University of California San Francisco.;Task Force for Global Health.; Published Date : 02/08/2024 Pages in Document : 35 pdf page Series : Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, 2024; v. 73, no. 1 DOI : http://dx.doi.org/10.15585/mmwr.rr7301a1 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports Papp, John R. et al. (2024). CDC Laboratory Recommendations for Syphilis Testing, United States, 2024. 73(1). http://dx.doi.org/10.15585/mmwr.rr7301a1 Papp, John R. et al. "CDC Laboratory Recommendations for Syphilis Testing, United States, 2024" 73, no. 1 (2024), http://dx.doi.org/10.15585/mmwr.rr7301a1 Papp, John R. et al. "CDC Laboratory Recommendations for Syphilis Testing, United States, 2024" vol. 73, no. 1, 2024, http://dx.doi.org/10.15585/mmwr.rr7301a1 Export RIS Citation Information.

:

Papp, John R. ;

Park, Ina U.

02/08/2024 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)

:

This report provides new CDC recommendations for tests that can support a diagnosis of syphilis, including serologic testing and methods for the ident...
MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 2, January 18, 2024

CITE Title : MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 2, January 18, 2024 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 01/18/2024 Pages in Document : 24 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 2 URL : https://stacks.cdc.gov/view/cdc/142694 Centers for Disease Control and Prevention (U.S.) (2024). MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 2, January 18, 2024. 73(2). Centers for Disease Control and Prevention (U.S.) "MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 2, January 18, 2024" 73, no. 2 (2024) Centers for Disease Control and Prevention (U.S.) "MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 2, January 18, 2024" vol. 73, no. 2, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

01/18/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Cannabis Use Among Students in Grades 8, 10, and 12, by Sex — King County, Washington, 2008–2021 / Precious Esie; Myduc TaPseudomonas Infection O...
Supplementary materials for: Detecting Mpox Cases Through Wastewater Surveillance — United States, August 2022–May 2023

CITE Title : Supplementary materials for: Detecting Mpox Cases Through Wastewater Surveillance — United States, August 2022–May 2023 Published Date : 01/18/2023 Pages in Document : 5 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR Morbidity Mortal Weekly Rep. 73(2): URL : https://stacks.cdc.gov/view/cdc/140513 Journal Title : Morbidity and Mortality Weekly Report (MMWR) "Supplementary materials for: Detecting" (2023). 73(2). "Supplementary materials for: Detecting Mpox Cases Through Wastewater Surveillance — United States, August 2022–May 2023" 73, no. 2 (2023) "Supplementary materials for: Detecting Mpox Cases Through Wastewater Surveillance — United States, August 2022–May 2023" vol. 73, no. 2, 2023 Export RIS Citation Information.

01/18/2023 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

SUPPLEMENTARY TABLE. Dates used for imputing* missing symptom onset dates for mpox cases -- SUPPLEMENTARY FIGURE 1. Decision tree for selecting wastew...
Supplementary Table. Weighted* prevalence of current† and frequent§ cannabis use, by sex and sex-based prevalence differences, by survey year and grade — Washington Healthy Youth Survey, King County, 2008–2021

CITE Title : Supplementary Table. Weighted* prevalence of current† and frequent§ cannabis use, by sex and sex-based prevalence differences, by survey year and grade — Washington Healthy Youth Survey, King County, 2008–2021 Published Date : January 18, 2024 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR. Morbidity and Mortality Weekly Report ; v. 73, no. 2 URL : https://stacks.cdc.gov/view/cdc/140555 Journal Title : Morbidity and Mortality Weekly Report (MMWR) "Supplementary Table. Weighted* prevalence" (2024). 73(2). "Supplementary Table. Weighted* prevalence of current† and frequent§ cannabis use, by sex and sex-based prevalence differences, by survey year and grade — Washington Healthy Youth Survey, King County, 2008–2021" 73, no. 2 (2024) "Supplementary Table. Weighted* prevalence of current† and frequent§ cannabis use, by sex and sex-based prevalence differences, by survey year and grade — Washington Healthy Youth Survey, King County, 2008–2021" vol. 73, no. 2, 2024 Export RIS Citation Information.

January 18, 2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary tables for Sex-specific Differences in Cannabis Use Among Students in Grades 8, 10, and 12 — King County, Washington, 2008–2021
Preventable Premature Deaths from the Five Leading Causes of Death in Nonmetropolitan and Metropolitan Counties, United States, 2010–2022

CITE Title : Preventable Premature Deaths from the Five Leading Causes of Death in Nonmetropolitan and Metropolitan Counties, United States, 2010–2022 Personal Author(s) : García, Macarena C.;Rossen, Lauren M.;Matthews, Kevin;Guy, Gery;Trivers, Katrina F.;Thomas, Cheryll C.;Schieb, Linda;Iademarco, Michael F.; Corporate Authors(s) : United States. Department of Health and Human Services. Office of the Assistant Secretary of Health. Office of Science and Medicine.;National Center for Health Statistics (U.S.);National Center for State, Tribal, Local, and Territorial Public Health Infrastructure and Workforce (U.S.);National Center for Injury Prevention and Control (U.S.);National Center for Chronic Disease Prevention and Health Promotion (U.S.); Published Date : 5 02 2024 Pages in Document : 14 pdf pages Series : Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, 2024; v. 73, no. 2 DOI : http://dx.doi.org/10.15585/mmwr.ss7302a1 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries García, Macarena C. et al. (2024). Preventable Premature Deaths from the Five Leading Causes of Death in Nonmetropolitan and Metropolitan Counties, United States, 2010–2022. 73(2). http://dx.doi.org/10.15585/mmwr.ss7302a1 García, Macarena C. et al. "Preventable Premature Deaths from the Five Leading Causes of Death in Nonmetropolitan and Metropolitan Counties, United States, 2010–2022" 73, no. 2 (2024), http://dx.doi.org/10.15585/mmwr.ss7302a1 García, Macarena C. et al. "Preventable Premature Deaths from the Five Leading Causes of Death in Nonmetropolitan and Metropolitan Counties, United States, 2010–2022" vol. 73, no. 2, 2024, http://dx.doi.org/10.15585/mmwr.ss7302a1 Export RIS Citation Information.

:

García, Macarena C. ;

Rossen, Lauren M.

5 02 2024 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)

:

Problem/Condition: A 2019 report quantified the higher percentage of potentially excess (preventable) deaths in U.S. nonmetropolitan areas compared wi...
Supplementary Table. Number and percentage of premature deaths that may have been prevented among persons aged <80 years from the five leading causes of death, by rural-urban county classification and state — National Vital Statistics System, United States, 2010-2022

CITE Title : Supplementary Table. Number and percentage of premature deaths that may have been prevented among persons aged <80 years from the five leading causes of death, by rural-urban county classification and state — National Vital Statistics System, United States, 2010-2022 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 05/02/2024 Pages in Document : 66 pdf pages Series : Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, 2024; v. 73, no. 2 URL : https://stacks.cdc.gov/view/cdc/147842 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries Centers for Disease Control and Prevention (U.S.) (2024). Supplementary Table. Number and percentage of premature deaths that may have been prevented among persons aged <80 years from the five leading causes of death, by rural-urban county classification and state — National Vital Statistics System, United States, 2010-2022. 73(2). Centers for Disease Control and Prevention (U.S.) "Supplementary Table. Number and percentage of premature deaths that may have been prevented among persons aged <80 years from the five leading causes of death, by rural-urban county classification and state — National Vital Statistics System, United States, 2010-2022" 73, no. 2 (2024) Centers for Disease Control and Prevention (U.S.) "Supplementary Table. Number and percentage of premature deaths that may have been prevented among persons aged <80 years from the five leading causes of death, by rural-urban county classification and state — National Vital Statistics System, United States, 2010-2022" vol. 73, no. 2, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

05/02/2024 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)

No Description
CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024

CITE Title : CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024 Personal Author(s) : Bachmann, Laura H.;Barbee, Lindley A.;Chan, Philip;Reno, Hilary;Workowski, Kimberly A.;Hoover, Karen;Mermin, Jonathan;Mena, Leandro; Corporate Authors(s) : National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.);Brown University;Washington University;Emory University; Published Date : 6 06 2024 Pages in Document : 11 pdf pages Series : Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, 2024; v. 73, no. 2 DOI : http://dx.doi.org/10.15585/mmwr.rr7302a1 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports Bachmann, Laura H. et al. (2024). CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024. 73(2). http://dx.doi.org/10.15585/mmwr.rr7302a1 Bachmann, Laura H. et al. "CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024" 73, no. 2 (2024), http://dx.doi.org/10.15585/mmwr.rr7302a1 Bachmann, Laura H. et al. "CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024" vol. 73, no. 2, 2024, http://dx.doi.org/10.15585/mmwr.rr7302a1 Export RIS Citation Information.

:

Bachmann, Laura H. ;

Barbee, Lindley A.

6 06 2024 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)

:

No vaccines and few chemoprophylaxis options exist for the prevention of bacterial sexually transmitted infections (STIs) (specifically syphilis, chla...
Supplementary Appendix A and B. A Standard Framework for Evaluating Large Health Care Data and Related Resources

CITE Title : Supplementary Appendix A and B. A Standard Framework for Evaluating Large Health Care Data and Related Resources Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 05/09/2024 Pages in Document : 13 pdf pages Series : Supplements: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR Suppl 2024;73(Suppl-3):1–13 URL : https://stacks.cdc.gov/view/cdc/151930 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Supplement Centers for Disease Control and Prevention (U.S.) (2024). Supplementary Appendix A and B. A Standard Framework for Evaluating Large Health Care Data and Related Resources. 73(3). Centers for Disease Control and Prevention (U.S.) "Supplementary Appendix A and B. A Standard Framework for Evaluating Large Health Care Data and Related Resources" 73, no. 3 (2024) Centers for Disease Control and Prevention (U.S.) "Supplementary Appendix A and B. A Standard Framework for Evaluating Large Health Care Data and Related Resources" vol. 73, no. 3, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

05/09/2024 | Supplements: Morbidity and Mortality Weekly Report (MMWR)

:

Framework Supplementary Appendix A and B
MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 3, January 25, 2024

CITE Title : MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 3, January 25, 2024 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 01/25/2024 Pages in Document : 19 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 3 URL : https://stacks.cdc.gov/view/cdc/146739 Centers for Disease Control and Prevention (U.S.) (2024). MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 3, January 25, 2024. 73(3). Centers for Disease Control and Prevention (U.S.) "MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 3, January 25, 2024" 73, no. 3 (2024) Centers for Disease Control and Prevention (U.S.) "MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 3, January 25, 2024" vol. 73, no. 3, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

01/25/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Prevalence of Cardiometabolic Diseases Among Racial and Ethnic Subgroups in Adults — Behavioral Risk Factor Surveillance System, United States, 2013...
Supplementary Table. Characteristics of COVID-19–Vaccinated Veterans With Mild-to-Moderate COVID-19 and Selected Immunosuppressive Conditions, by Receipt or Non- Receipt of an Antiviral Medication (N = 1,196) — Veterans Health Administration, United States, March–September 2022

CITE Title : Supplementary Table. Characteristics of COVID-19–Vaccinated Veterans With Mild-to-Moderate COVID-19 and Selected Immunosuppressive Conditions, by Receipt or Non- Receipt of an Antiviral Medication (N = 1,196) — Veterans Health Administration, United States, March–September 2022 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 01/25/2024 Pages in Document : 2 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 3 URL : https://stacks.cdc.gov/view/cdc/141955 Centers for Disease Control and Prevention (U.S.) (2024). Supplementary Table. Characteristics of COVID-19–Vaccinated Veterans With Mild-to-Moderate COVID-19 and Selected Immunosuppressive Conditions, by Receipt or Non- Receipt of an Antiviral Medication (N = 1,196) — Veterans Health Administration, United States, March–September 2022. 73(3). Centers for Disease Control and Prevention (U.S.) "Supplementary Table. Characteristics of COVID-19–Vaccinated Veterans With Mild-to-Moderate COVID-19 and Selected Immunosuppressive Conditions, by Receipt or Non- Receipt of an Antiviral Medication (N = 1,196) — Veterans Health Administration, United States, March–September 2022" 73, no. 3 (2024) Centers for Disease Control and Prevention (U.S.) "Supplementary Table. Characteristics of COVID-19–Vaccinated Veterans With Mild-to-Moderate COVID-19 and Selected Immunosuppressive Conditions, by Receipt or Non- Receipt of an Antiviral Medication (N = 1,196) — Veterans Health Administration, United States, March–September 2022" vol. 73, no. 3, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

01/25/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

No Description

1 - 20 / 180